Novartis launches first large-scale smartphone-based study in multiple sclerosis
August 23, 2017Research and Development MS, Novartis, life sciences, multiple sclerosis, pharma, pharmaceuticals
Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …
Ultragenyx stumbles in P3 trial for severe muscle disease
August 23, 2017Research and Development Ultragenyx, biotech, drugs, pharma, pharmaceutical
Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …
Research unveils new drug targets for more effective treatment of liver disease
August 22, 2017Manufacturing and Production, Research and Development life sciences, liver, liver cancer, liver disease, pharma, pharmaceuticals
Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …
AstraZeneca strikes mRNA-based partnership in respiratory disease
August 22, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Ethris, MedImmune, mrna, pharma, pharmaceuticals
AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …
Hikma risks a stratospheric 430% price increase on product
August 22, 2017Manufacturing and Production, Sales and Marketing Hikma, biotech, drugs, generics, pharma, pharmaceutical
It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …
FDA approves Ironwood’s combination gout treatment
August 22, 2017Manufacturing and Production, Sales and Marketing Duzallo, FDA, Ironwood Pharmaceuticals, gout, life sciences, pharma, pharmaceuticals
Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …
Outcry after private hospitals receive tax breaks instead of NHS
August 22, 2017Manufacturing and Production, Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …
Taking science and making people feel connected to it
August 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical, rare diseases
Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …
Antibacterial power of mother’s milk revealed
August 21, 2017Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …
US Congressmen accuse Teva of price hikes over 1,000%
August 21, 2017Sales and Marketing Copaxone, Teva, life sciences, medicine, multiple sclerosis, pharma, pharmaceutical, price hiking
A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …
Samsung Bioepis collaborates to make inroads into original drugs
August 21, 2017Research and Development, Sales and Marketing Samsung Bioepis, Takeda, biotech, drugs, pharma, pharmaceutical
Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …
New study debunks hypothesis that antidepressants are ineffective
August 21, 2017Research and Development, Sales and Marketing SSRIs, anti-depressants, citalopram, life sciences, medicine, paroextine, pharma, pharmaceuticals
A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …
Novartis begins ‘next-generation’ malaria treatment trial
August 21, 2017Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical
Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …
Top Ten most popular articles on Pharmafile.com this week
August 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten
A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …
The pendulum swing of generic drug prices
August 18, 2017Medical Communications biotech, drugs, generics, pharma, pharmaceutical
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …
Pfizer’s leukaemia drug gets opposing regulatory decisions on either side of the Atlantic
August 18, 2017Medical Communications, Sales and Marketing Besponsa, Cancer, FDA, NICE, Pfizer, leukaemia, pharma, pharmaceutical
Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval …
AZ and MSD secure three bits of good news on key drug
August 18, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical
It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …
Longest-serving chief exec in NHS sacked for ‘gross misconduct’
August 18, 2017Medical Communications NHS, Newcastle, biotech, drugs, pharma, pharmaceutical
Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he …
Where will the next cardiovascular breakthrough come from?
August 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical
British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …
Independent research may change the immunotherapy game
August 17, 2017Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical
Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
